ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
239.07
+0.88 (0.37%)
Nov 17, 2026, 3:45 PM EST - Market open

ResMed Stock Forecast

Stock Price Forecast

According to 20 analysts polled by S&P Global, ResMed stock has a consensus rating of "Buy" and an average price target of $264.33. The average 1-year stock price forecast is 10.57% higher than the current stock price, while the lowest is $210 (-12.16%) and the highest is $320 (+33.85%).

Price Target: $264.33 (+10.57%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$210$264.33$270$320
Change-12.16%+10.57%+12.94%+33.85%

Analyst Ratings

The average analyst rating for ResMed stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy867777
Buy111222
Hold81011101010
Sell000000
Strong Sell111111
Total181820202020

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Buy
Reiterates
$320
BuyReiterates$320+33.85%Nov 2, 2026
Citi
Citi
Hold
Maintains
$240 → $270
HoldMaintains$240 → $270+12.94%Nov 2, 2026
Morgan Stanley
Morgan Stanley
Hold
Maintains
$233
HoldMaintains$233-2.54%Oct 30, 2026
Needham
Needham
Hold
Maintains
n/a
HoldMaintainsn/an/aOct 30, 2026
Piper Sandler
Piper Sandler
Hold
Maintains
$225 → $260
HoldMaintains$225 → $260+8.75%Oct 30, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
5.83B
from 5.65B
Increased by 3.12%
Revenue Next Year
6.21B
from 5.83B
Increased by 6.43%
EPS This Year
12.14
from 11.17
Increased by 8.69%
EPS Next Year
13.23
from 12.14
Increased by 8.94%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingJun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026Jun 30, 2027
Revenue
3.58B4.22B4.69B5.15B5.65B5.83B
Revenue Growth
11.93%18.02%10.95%9.84%9.85%3.12%
Gross Profit
2.06B2.39B2.69B3.09B3.48B3.64B
Gross Margin
57.68%56.50%57.38%59.99%61.62%62.46%
Operating Income
1.00B1.15B1.38B1.69B1.92B2.09B
Net Income
779.44M897.56M1.02B1.40B1.52B1.69B
EPS
----11.1712.14
EPS Growth
----16.96%8.69%
Forward PE
34.1030.8222.8625.3216.4219.69
Dividend / Share
1.681.761.922.122.402.67
Dividend Growth
5.66%4.76%9.09%10.42%13.21%11.33%
Free Cash Flow
----1.65B1.64B
No. Analysts
-----29
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202720282029
High6.0B
Avg5.8B
Low5.8B

Revenue Growth

Revenue Growth202720282029
High
5.4%
Avg
3.1%
Low
2.3%

EPS Forecast

EPS202720282029
High12.23
Avg12.14
Low12.02

EPS Growth

EPS Growth202720282029
High
9.5%
Avg
8.7%
Low
7.6%